Daiichi Sankyo Company, Limited

¥2,767As of Sun 8 Nov 2026, 12:00 UTC
TSE:4568Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 14.36%
Div yield 3.61%
ROE —
Drug Manufacturers (General)
Beta (5Y) (0.12)
PE TTM 18.09
TSR TTM (22.19%)
Mkt cap ¥5.042T
ROIC 18.39%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥3,308
19.57%
(10.79%)
Hold 4|9|12|8|8
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
34.53
33.52
36.81
40.80
7.87%
4.67%
5.35%
18.07%
Revenue¥B
302.3
313.8
317.2
321.7
10.53%
16.65%
12.48%
12.28%
Peers (US$32.01B)
Cap (US$)
PE
38.54B
15.74x
28.14B
11.52x
36.71B
106.3x
Capital
TTM
5Y
10Y
Leveragex
0.670
0.389
0.449
EBIT/Intx
0.996
0.542
0.514
Own earn%
16.00
268.66
183.00
Sh yield%
32.50
25.47
25.61
Owners
Insiders/Inst%
8.68
89.26
Short interest%
0.62
SBC / revenue%
4.29
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
27–33
$1 testx
—
Incr. ROIC%
4